Immutep Limited (ASX:IMM) Announces Positive Phase I Results for IMP761
Immutep (ASX:IMM) reports positive Phase I results for IMP761, showing significant T cell suppression and favourable safety profile.
Category: Companies
Stockland (ASX:SGP) Announces 2H25 Estimated Distribution and Distribution Reinvestment Plan
Stockland (ASX:SGP) announces a full-year distribution of 25.2c per Ordinary Stapled Security and introduces a Distribution Reinvestment Plan.
Smartpay Holdings Limited (ASX:SMP) Finalises Scheme with Shift4 Payments
Smartpay Holdings Limited (ASX:SMP) finalises a Scheme Implementation Agreement with Shift4 Payments to be acquired at NZ$1.20 per share.
Metcash Limited (ASX:MTS) Announces FY25 Results
Metcash Limited (ASX:MTS) reports FY25 results with revenue growth and declares a final dividend of 18.0 cps fully franked.
Smartpay Holdings Limited (ASX:SMP) Announces Acquisition by Shift4 Payments
Shift4 Payments announces the acquisition of Smartpay Holdings Limited (ASX:SMP) at NZ$1.20 per share, pending regulatory and shareholder approvals.
AML3D Limited (ASX:AL3) Opens Advanced Manufacturing Facility in Ohio
AML3D Limited (ASX:AL3) opens a new advanced manufacturing facility in Ohio to support US submarine programs and the AUKUS partnership.
Engenco Limited (ASX:EGN) Announces Unconditional Takeover Offer by Elph Investments
Engenco Limited (ASX:EGN) announces an unconditional takeover offer by Elph Investments, advising shareholders to accept by June 27.
Saturn Metals Limited (ASX:STN) Reports Strong Drilling Results at Apollo Hill
Saturn Metals Limited (ASX:STN) announces high-grade gold intercepts at Apollo Hill, indicating strong resource growth potential.
Riedel Resources (ASX:RIE) Announces $1.3M Capital Raising
Riedel Resources (ASX:RIE) initiates a $1.3M capital raise through placement and SPP to advance its Kingman Gold Project in Arizona.
Neurizon Therapeutics Limited (ASX:NUZ) Reports New Preclinical Data Supporting ALS Treatment
Neurizon Therapeutics (ASX:NUZ) announces positive preclinical results for NUZ-001, highlighting its potential as a transformative ALS therapy.